Low episodic memory performance in cognitively normal elderly subjects is associated with increased posterior cingulate gray matter N-acetylaspartate: a 1H MRSI study at 7 Tesla

Low episodic memory performance characterizes elderly subjects at increased risk for Alzheimer's disease (AD) and may reflect neuronal dysfunction within the posterior cingulate cortex and precuneus (PCP) region. To investigate a potential association between cerebral neurometabolism and low episodic memory in the absence of cognitive impairment, tissue-specific magnetic resonance spectroscopic imaging at ultrahigh field strength of 7 Tesla was used to investigate the PCP region in a healthy elderly study population (n = 30, age 70 ± 5.7 years, Mini-Mental State Examination 29.4 ± 4.1). The Verbal Learning and Memory Test (VLMT) was administered as part of a neuropsychological battery for assessment of episodic memory performance. Significant differences between PCP gray and white matter could be observed for glutamate-glutamine (p = 0.001), choline (p = 0.01), and myo-inositol (p = 0.02). Low Verbal Learning and Memory Test performance was associated with high N-acetylaspartate in PCP gray matter (p = 0.01) but not in PCP white matter. Our data suggest that subtle decreases in episodic memory performance in the elderly may be associated with increased levels of N-acetylaspartate as a reflection of increased mitochondrial energy capacity in PCP gray matter.

[1]  Claudius Mueller,et al.  Longitudinal Metabolic and Cognitive Changes in Mild Cognitive Impairment Patients , 2008, Alzheimer disease and associated disorders.

[2]  B. Meier,et al.  Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .

[3]  Peter Boesiger,et al.  Slice‐selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H‐MRSI of the human brain at 7 T with minimal signal loss , 2009, NMR in biomedicine.

[4]  G. Fein,et al.  Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. , 1996, Archives of neurology.

[5]  F. Jessen,et al.  Treatment monitoring and response prediction with proton MR spectroscopy in AD , 2006, Neurology.

[6]  W. Bogner,et al.  High‐resolution mapping of human brain metabolites by free induction decay 1H MRSI at 7 T , 2012, NMR in Biomedicine.

[7]  Keith A. Johnson,et al.  Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[8]  Cindee M. Madison,et al.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.

[9]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[10]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[11]  P. Barker,et al.  Single‐voxel proton MRS of the human brain at 1.5T and 3.0T , 2001, Magnetic resonance in medicine.

[12]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[13]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[14]  Alexander Hammers,et al.  Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.

[15]  C. Jack,et al.  MRS in presymptomatic MAPT mutation carriers , 2010, Neurology.

[16]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[17]  A. Picco,et al.  Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints. , 2014, Journal of Alzheimer's disease : JAD.

[18]  Anke Henning,et al.  Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype , 2015, Neurobiology of Aging.

[19]  S. Leh,et al.  Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects , 2014, Front. Aging Neurosci..

[20]  B. Winblad,et al.  The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. , 2000, Archives of neurology.

[21]  Stefan Teipel,et al.  Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  C. Elger,et al.  Rey Auditory-Verbal Learning Test: structure of a modified German version. , 1997, Journal of clinical psychology.

[23]  Terry E. Goldberg,et al.  APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain , 2014, Biological Psychiatry.

[24]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[25]  M. Albert Changes in cognition , 2011, Neurobiology of Aging.

[26]  Dimitrios Kapogiannis,et al.  Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network , 2013, NeuroImage.

[27]  D. Bonekamp,et al.  Quantitation of NAA in the brain by magnetic resonance spectroscopy. , 2006, Advances in experimental medicine and biology.

[28]  Jamie Near,et al.  Spectral Quantification and Pitfalls in Interpreting Magnetic Resonance Spectroscopic Data: What To Look Out For , 2014 .

[29]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[30]  Ravi S. Menon,et al.  Imaging at high magnetic fields: initial experiences at 4 T. , 1993, Magnetic resonance quarterly.

[31]  C. Gasparovic,et al.  Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. , 2001, Journal of neurotrauma.

[32]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[33]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[34]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[35]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[36]  Ariane Fillmer,et al.  Reduction of voxel bleeding in highly accelerated parallel 1H MRSI by direct control of the spatial response function , 2015, Magnetic resonance in medicine.

[37]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[38]  R. Wu,et al.  Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study , 2012, Neuroradiology.

[39]  J. Morris,et al.  The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.

[40]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[41]  D. Head,et al.  Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly , 2010, Biological Psychiatry.

[42]  M. Buonocore,et al.  MR spectroscopic studies of the brain in psychiatric disorders. , 2012, Current topics in behavioral neurosciences.

[43]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[44]  M N Rossor,et al.  MRS shows abnormalities before symptoms in familial Alzheimer disease , 2006, Neurology.

[45]  Mark A Mintun,et al.  Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. , 2009, Archives of neurology.

[46]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[47]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[48]  Silke Lux,et al.  Verbaler Lern- und Merkfähigkeitstest , 2001 .

[49]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[50]  M W Weiner,et al.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[51]  M. Giroud,et al.  N‐Acetylaspartate: a literature review of animal research on brain ischaemia , 2004, Journal of neurochemistry.

[52]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[53]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[54]  S. Black,et al.  Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s disease , 1998, Neuropsychologia.

[55]  C. Studholme,et al.  Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI) , 2009, Magnetic resonance in medicine.

[56]  J. Laczó,et al.  Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented older adults. , 2014, Journal of Alzheimer's disease : JAD.

[57]  D. Selkoe,et al.  The therapeutics of Alzheimer's disease: Where we stand and where we are heading , 2013, Annals of neurology.

[58]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[59]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[60]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[61]  A. Vezzani,et al.  In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity , 2012, Epilepsia.

[62]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[63]  T. Tombaugh Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[64]  Elizabeth C Mormino,et al.  Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. , 2012, Cerebral cortex.

[65]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[66]  J. Clark,et al.  N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.

[67]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[68]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[69]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[70]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[71]  Heinrich Lanfermann,et al.  Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy , 2009, Psychiatry Research: Neuroimaging.

[72]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[73]  Bedda L. Rosario,et al.  Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.

[74]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[75]  Jennifer Weuve,et al.  Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia , 2015, Neurology.

[76]  Benjamin J. Shannon,et al.  Parietal lobe contributions to episodic memory retrieval , 2005, Trends in Cognitive Sciences.

[77]  Daniel Rueckert,et al.  Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest , 2008, NeuroImage.

[78]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[79]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[80]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[81]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[82]  R. Lipton,et al.  Memory impairment on free and cued selective reminding predicts dementia , 2000, Neurology.

[83]  Patrizia Mecocci,et al.  Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy , 2006, Neurobiology of Aging.

[84]  Peter B Barker,et al.  Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. , 2015, Magnetic resonance imaging.

[85]  Ariane Fillmer,et al.  Constrained image‐based B0 shimming accounting for “local minimum traps” in the optimization and field inhomogeneities outside the region of interest , 2015, Magnetic resonance in medicine.

[86]  Kaori Takehara-Nishiuchi,et al.  The cortical structure of consolidated memory: A hypothesis on the role of the cingulate–entorhinal cortical connection , 2013, Neurobiology of Learning and Memory.

[87]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[88]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[89]  R. Brookshire,et al.  The Boston Naming Test: Revised Administration and Scoring Procedures and Normative Information for Non-Brain-Damaged Adults , 1989 .

[90]  Hans Hoogduin,et al.  High‐field MRS of the human brain at short TE and TR , 2011, NMR in biomedicine.

[91]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[92]  Aaron Carass,et al.  Brain metabolite alterations and cognitive dysfunction in early Huntington's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[93]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[94]  E. Kaplan,et al.  The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. , 1995, Archives of neurology.

[95]  Roland Kreis,et al.  The trouble with quality filtering based on relative Cramér‐Rao lower bounds , 2016, Magnetic resonance in medicine.

[96]  F. Zang,et al.  Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice , 2010, Dementia and Geriatric Cognitive Disorders.

[97]  Paul Maruff,et al.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. , 2007, Brain : a journal of neurology.

[98]  Alessio Fracasso,et al.  FLAIR images at 7 Tesla MRI highlight the ependyma and the outer layers of the cerebral cortex , 2015, NeuroImage.

[99]  A. Simmons,et al.  Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study , 1997, Neurology.

[100]  Brigitte Landeau,et al.  Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.

[101]  J. Baron,et al.  Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. , 2003, Brain : a journal of neurology.

[102]  R. Sperling,et al.  Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation , 2008, Proceedings of the National Academy of Sciences.

[103]  J. Pettegrew,et al.  N‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain , 1992, Neurology.

[104]  L. Mosconi,et al.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[105]  Florence Pasquier,et al.  Early diagnosis of dementia: neuropsychology , 1999, Journal of Neurology.

[106]  A. Cavanna,et al.  The precuneus: a review of its functional anatomy and behavioural correlates. , 2006, Brain : a journal of neurology.

[107]  T. Goldberg,et al.  Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. , 2011, Archives of general psychiatry.

[108]  C. Helmstaedter,et al.  VLMT: Verbaler Lern- und Merkfähigkeitstest: Ein praktikables und differenziertes Instrumentarium zur Prüfung der verbalen Gedächtnisleistungen , 1990 .

[109]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Eric M Reiman,et al.  Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. , 2007, Archives of neurology.

[111]  Keith A. Johnson,et al.  Preclinical Alzheimer disease—the challenges ahead , 2013, Nature Reviews Neurology.